Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  Astellas Pharma Inc.    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization1 3 189 4043 186 2313 105 3952 665 547--
Entreprise Value (EV)1 2 844 1562 875 1572 777 5452 215 7962 087 8501 947 414
P/E ratio 19,9x14,4x16,0x13,0x11,4x10,9x
Yield 2,23%2,29%-2,94%3,23%3,51%
Capitalization / Revenue 2,45x2,44x2,39x2,09x1,98x1,93x
EV / Revenue 2,19x2,20x2,14x1,74x1,55x1,41x
EV / EBITDA 10,2x9,35x8,95x6,71x5,73x5,20x
Price to Book 2,51x2,49x2,41x1,89x1,73x1,60x
Nbr of stocks (in thousands) 1 976 0871 921 1521 858 4051 857 524--
Reference price (JPY) 1 6141 6591 6711 4351 4351 435
Last update 04/26/201804/25/201905/14/202010/06/202010/06/202010/06/2020
1 JPY in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales1 1 300 3161 306 3481 300 8431 273 9951 346 4931 379 692
EBITDA1 278 121307 370310 387330 055364 326374 184
Operating profit (EBIT)1 213 258243 912243 991254 954287 710294 904
Operating Margin 16,4%18,7%18,8%20,0%21,4%21,4%
Pre-Tax Profit (EBT)1 218 113248 967245 350255 122288 980294 997
Net income1 164 679222 265195 411204 197230 715235 498
Net margin 12,7%17,0%15,0%16,0%17,1%17,1%
EPS2 81,1115104111126132
Dividend per Share2 36,038,0-42,246,450,3
Last update 04/26/201804/25/201905/14/202010/28/202010/28/202010/28/2020
1 JPY in Million
2 JPY
Estimates
Balance Sheet Analysis
Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 345 248311 074327 850449 751577 697718 133
Leverage (Debt / EBITDA) -1,24x-1,01x-1,06x-1,36x-1,59x-1,92x
Free Cash Flow1 190 815233 440-167 795231 513226 803228 522
ROE (Net Profit / Equities) 13,0%17,6%15,3%15,3%16,3%15,6%
Shareholders' equity1 1 266 7621 262 8691 277 1961 332 2671 414 9941 509 362
ROA (Net Profit / Asset) 11,9%13,3%11,6%9,47%10,2%9,70%
Assets1 1 388 8931 676 5161 678 8582 157 0052 261 9092 427 817
Book Value Per Share2 642667694758827894
Cash Flow per Share2 113148140147147141
Capex1 25 07725 19041 26737 60038 40039 000
Capex / Sales 1,93%1,93%3,17%2,95%2,85%2,83%
Last update 04/26/201804/25/201905/14/202010/28/202010/28/202010/30/2020
1 JPY in Million
2 JPY
Estimates
Finances - Leverage
Financial data source
© 2020 S&P Global Market Intelligence
Key data
Capitalization (JPY)
2 665 546 855 335
Capitalization (USD)
25 471 550 869
Net sales (JPY)
1 300 843 000 000
Net sales (USD)
12 442 563 295
Number of employees
15 883
Sales / Employee (JPY)
81 901 593
Sales / Employee (USD)
783 389
Free-Float
99,2%
Free-Float capitalization (JPY)
2 643 929 730 174
Free-Float capitalization (USD)
25 264 980 986
Avg. Exchange 20 sessions (JPY)
6 600 981 345
Avg. Exchange 20 sessions (USD)
63 138 387
Average Daily Capital Traded
0,2%
EPS & Dividend